ONXEO (EPA:ALONX) | WebDisclosure

PRESS RELEASE

published on 10/30/2025 at 09:05, 7 months 29 days ago

Half-Year Financial Report 2025
PRESS RELEASE

published on 10/30/2025 at 09:04, 7 months 29 days ago

Rapport financier semestriel 2025
BRIEF

published on 10/30/2025 at 09:03, 7 months 29 days ago

Bilan financier et stratégique de Valerio Therapeutics pour le 1er semestre 2025

Recentrage Stratégique Valerio Therapeutics Résultats Financiers 2025 Plateformes V-Body Recherche Partenariats
BRIEF

published on 10/30/2025 at 09:03, 7 months 29 days ago

Valerio Therapeutics' financial and strategic review for the first half of 2025

Strategic Refocusing Valerio Therapeutics 2025 Financial Results V-Body Platforms Seeking Partnerships
PRESS RELEASE

published on 10/30/2025 at 09:00, 7 months 29 days ago

Press Release Publication Half-Year Financial Report 2025
Valerio Therapeutics S.A. announces first-half 2025 financial results, discontinuation of clinical activities, and strategic refocus on preclinical R&D. Strengthened financial structure through shareholder advances and capital increases

Financial Results Valerio Therapeutics First-half 2025 Preclinical R&D Shareholder Advances
PRESS RELEASE

published on 10/30/2025 at 08:58, 7 months 29 days ago

Communiqué de presse Mise à disposition du rapport semestriel 2025
Valerio Therapeutics annonce ses résultats financiers du 1er semestre 2025 et fait le point sur ses activités. Renforcement de la R&D préclinique avec les plateformes V-Body et chimie intégrée

Résultats Financiers Valerio Therapeutics R&D Préclinique V-Body Chimie Intégrée
BRIEF

published on 03/19/2025 at 15:32, 1 year 3 months ago

Valerio Therapeutics Announces Board Members and Their Roles

Board Members Valerio Therapeutics Corporate Roles Paris-based Company Executive Responsibilities
BRIEF

published on 03/19/2025 at 15:32, 1 year 3 months ago

Valerio Therapeutics annonce la composition de son conseil d'administration et leurs fonctions

Membres Du Conseil D'administration Valerio Therapeutics Rôles En Entreprise Entreprise Basée À Paris Responsabilités Exécutives
PRESS RELEASE

published on 03/19/2025 at 15:27, 1 year 3 months ago

Inside Information / Other news releases
Valerio Therapeutics announces new board members and their positions in other companies as of March 19, 2025

Board Members Positions Valerio Therapeutics Other Companies March 19 2025
BRIEF

published on 03/19/2025 at 12:35, 1 year 3 months ago

Valerio Therapeutics Board Meeting Decisions

Director Changes Shareholder Meeting Share Split Board Resolutions Article Amendments

Published on 06/27/2026 at 16:50, 21 hours 54 minutes ago

Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 1 day 13 hours ago

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day 14 hours ago

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 15 hours ago

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 15 hours ago

Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada

View all ACCESSWIRE

Published on 06/27/2026 at 00:05, 1 day 14 hours ago

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day 14 hours ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 15 hours ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 15 hours ago

EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 1 day 15 hours ago

EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE

View all EQS

Published on 06/26/2026 at 17:45, 1 day 20 hours ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 1 day 20 hours ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 1 day 20 hours ago

Descriptif du programme de rachat d'actions
Published on 06/26/2026 at 14:44, 1 day 23 hours ago

Safran information
Published on 06/26/2026 at 14:44, 1 day 23 hours ago

Information Safran

View all LES ECHOS COMFI WIRE

News